If there is any information that you would like included on this page please contact Alexandra Fullem (alexfullem@gmail.com). The website is updated approximately twice a month.
PDP Press Releases/ statements
• 28 Oct: IAVI awarded $36 million from BARDA for Bundibugyo virus vaccine development
• 1 Oct: Sustaining the UK’s malaria science leadership at Labour Party Conference
• 7 Oct: Malaria Science Index highlights the importance of investment and partnerships in malaria innovation
• 12 Nov: New WHO Report Highlights Promise of TB Innovation and Urgent Need to Accelerate Progress
• 16 Nov: Union Conference to Feature Promising Findings from TB Alliance on Novel TB Drug Candidate Sorfequiline and the BPaL DR-TB Regimen
• 17 Nov: TB Alliance Appoints Jerome H. Kim, MD as next President and Chief Executive Officer
• 22 Jul: Last-resort antibiotics remain out of reach in Latin America and the Caribbean, review warns
• 29 Oct: Ares and PATH bet on better health
• 29 Oct: PATH and iBody partner to develop a diagnostic for Nipah virus and Hendra virus
• 20 Oct: MMV recognized as a “Very High Performer” in the Global Health 50/50 Gender & Health Index for fifth consecutive year
• 23 Oct: African healthcare providers favour a long-acting injectable to simplify malaria prevention
• 2 Nov: Project to develop dengue treatment pre-selected by the Global Coalition for Local and Regional Production, Innovation, and Equitable Access
• 27 Oct: Kenya becomes first African country to join the Dengue Alliance.
• 8 Oct: FIND Board appoints Dr Jutta Reinhard-Rupp as FIND’s Chief Executive Officer
• 9 Nov: International Vaccine Institute secures seed funding from Coefficient Giving to establish BRIGHT Fund for global health innovation
• 12 Nov: International Vaccine Institute adopts 2027–2031 Strategy to advance vaccine innovation and strengthen global health impact
• 17 Nov: International Vaccine Institute announces leadership transition as Director General Jerome H. Kim accepts new role
MDGH
PDP Funder News/Announcements
• 2 Nov: U.S. FDA approves first generic injectable lenacapavir for HIV prevention. Unitaid
• 9 Nov: Unitaid launches US$10.9 million initiative to protect essential health products from rising temperatures. Unitaid
• 12 Nov: Flagship Pioneering and Gates Foundation Launch Collaboration to Accelerate Advancement in Global Health and Development to Benefit Underserved Populations. Gates Foundation
Funder Announcement Archives
• 2014 PDP Funder Announcements
• 2013 PDP Funder Announcements
New PDP Publications
• 11 Oct: Research, innovation and product development in the evolving global health ecosystem: an essential global public good. Numerous PDPs
• 19 Oct: Strengthening WHO’s role in public health innovation: a PDP perspective. Numerous PDPs
Other Reports/ Publications
• 21 Oct: Pipeline Report » 2026 Tuberculosis Vaccines. TAG
Related Press Releases/ Announcements/Articles
• 1 Oct: Sluggish donor response to CEPI’s pandemic prevention ask. Development Today
• 2 Nov: Mark Dybul at The Global Fund: Back To First Principles; Focus on Controlling Epidemics; Cautious on The Expansion of Scope; Signals Collaboration With Gavi. Geneva Health Files
• 2 Nov: Five overlooked steps to identify new epidemics, fast. Nature
• 2 Nov: U.S. approval of cheap, generic HIV prevention shot may boost global rollout. Science
• 2 Nov: First ever trial of long-acting injection against malaria to launch in Africa. The Telegraph
• 2 Nov: Malaria control: Who decides Africa’s gene-drive future?. SciDevNet
• 3 Nov: A promising new drug could turn the tide against HIV. ABC News
• 3 Nov: Global Fund Board Approves New Financing Mechanism to Accelerate Progress Against Malaria and Marks Leadership Transition. The Global Fund
• 3 Nov: As Global Health Aid Dries Up, Non-Profit Drug Development Faces New Challenges. Health Policy Watch
• 4 Nov: Two new candidate vaccines to join Ebola trial as treatment research advances. WHO
• 4 Nov: Insights on global health reform discussions, trends and perspectives: November 2026. Insights for International Politics and Diplomacy for Health
• 5 Nov: New malaria drug to be unveiled to stay ahead of resistance. Daily Nation
• 5 Nov: Africa Ready: Rebuilding sovereignty in Africa’s new health era. Devex
• 5 Nov: Re-securitising antimicrobial resistance: how resurgent health security thinking threatens collective action. The Lancet Microbe
• 6 Nov A review of global health architecture reform efforts—navigating between reform and fragmentation. The Lancet
• 6 Nov: Health is national security: why TB vaccines must be on the UK’s G20 agenda. Results UK
• 6 Nov: An introduction to Global Public Value. Jonathan Glennie Substack
• 6 Nov: New Data Show Twice-Yearly Lenacapavir Achieved Nearly Twice the One-Year Persistence of Daily Oral F/TDF in HIV Prevention. Gilead
• 7 Nov: Ghana to fully fund its own vaccines by 2030 as President Mahama announces Gavi exit. Modern Ghana
• 9 Nov: Prioritising malaria interventions to maximise health: the role of economic evaluation. The Lancet Global Health
• 9 Nov: Wider use of Ervebo vaccine urged as DR Congo Ebola outbreak nears 11,000 cases. CIDRAP
• 9 Nov: UCT’s H3D centre recognised in major global health report. UCT
• 9 Nov: India–Africa pharmaceutical cooperation and the future of global health. Global Health Action
• 10 Nov: Science is getting closer to beating malaria, so what’s still in the way? 3 areas where action can make an impact. The Conversation
• 10 Nov: Can two new vaccines help turn the tide against Bundibugyo Ebola?. Gavi
• 10 Nov: Pharmaceutical companies are showing what’s possible on access to medicine, but must go further to deliver impact at scale. Access to Medicines Foundation
• 10 Nov: PAN-TB Collaboration to Launch New Clinical Trial of Next-Generation Tuberculosis Treatment Regimen. Gates MRI
• 10 Nov: The Health Financing Crisis Demands Innovation: Lessons From Pooled Sputum Testing for TB. Health Policy Watch
• 10 Nov: After 20 years, how much has Big Pharma changed on access? Devex
• 10 Nov: MPP, SwiftPharma and CSIR sign technology transfer agreement to advance STI prevention and strengthen manufacturing capacity in Africa. MPP
• 10 Nov: WHO and African Medicines Agency advance regulatory cooperation at inaugural Agency Week in Kigali. WHO
• 11 Nov: From Research to Real Life: WHO Puts Communities at the Heart of Science and Health. DeviDiscourse
• 11 Nov: Opinion: We need to test drugs on newborns despite the risks. Financial Times
• 11 Nov: Preventing Malaria Infections and Moving toward Malaria Elimination. NEJM
• 11 Nov: Anthropic bought a one-person, AI-powered biotech: is this drug discovery’s future?. Nature
• 12 Nov: New Global Fund malaria mechanism gives GiveWell a say in what gets funded. Devex
• 12 Nov: Malaria aid cuts will rob children of their futures – here’s what we can do to stop it. The Independent
• 12 Nov: Ebola vaccine lessons. Science
• 12 Nov: WHO: Funding cuts threaten global progress against TB. CIDRAP
• 12 Nov: CARB-X funds UNSW Sydney to develop novel antibiotic targeting drug-resistant Gram-negative bacterial infections. CARB-X
• 12 Nov: Beyond repair: a radical reimagining of global health that is fit for Africa. The Lancet Regional Health Africa
• 12 Nov: Tuberculosis Killed A Million People In 2025, Even As Aid Cuts Threaten Progress. Forbes
• 12 Nov: Amid challenges, countries increase domestic investment to protect progress against tuberculosis. WHO
• 13 Nov: Scientists breed a 'pan-African' malaria parasite to build a better whole-parasite malaria vaccine. MedicalXpress
• 13 Nov: Communities must help shape innovation, not just benefit from it. GHTC
• 14 Nov: Access to medicines: innovations not reaching those in need. The Lancet
• 16 Oct: World Health $ummit: The Necessary Evil of Capitalist Global Health?. IHP
• 16 Oct: First participants vaccinated with Oxford's CEPI-backed Lassa shot in Ghana. CEPI
• 15 Nov: Opinion: Why Florida should keep investing in global health research. The Gainseville Sun
• 16 Nov: Rethinking How to Fight the World’s Deadliest Infection. National Geographic
• 16 Nov: WHO sounds the alarm on antimicrobial resistance threat. MedicalXpress
• 16 Nov: HIV drug lenacapavir found to disrupt virus formation, creating giant noninfectious particles. MedicalXpress
• 16 Nov: Krishnan Ramanathan, Ph.D., appointed chief executive officer of Gates Medical Research Institute. Gates MRI
• 19 Oct: How WHO's pandemic hub plans to identify all new threats within 24 hours. Devex
• 17 Nov: Could AI help us develop vaccines against viruses that don’t yet exist?. Gavi
• 17 Nov: Open letter to the candidates for the post of WHO Director-General. IFPMA
• 20 Oct: As Ebola epidemic rages, Congo bets on high-stakes ‘hope’ vaccine trial. Science
• 20 Oct: New TB vaccines are coming. How are countries preparing for the rollout?. Gavi
• 20 Oct: Is tuberculosis eradication actually in sight?. Devex
• 21 Oct: African trial optimises dose of drug with potential to improve outcomes in children with severe malaria. Imperial College
• 21 Oct: Now What with Injectable LEN for PrEP? How to Translate Ambition into Accelerated Delivery and Impact. AVAC
• 21 Oct: Sevuparin in children with severe malaria: a phase I safety and dose-finding trial. Nature
• 21 Oct: Drug-resistant infections linked to $3.5 trillion in global economic losses in 2021. CIDRAP
• 22 Oct: Gavi and UNICEF secure lower malaria vaccine price, saving US$ 50 million for childhood immunisation programmes. Gavi
• 22 Oct: A five-year look into how a malaria vaccine changed Ghana. The World
• 22 Oct: African health manufacturers need reliable buyers, not just investment. Devex
• 22 Oct: Global health deserves better criticism. The Lancet Global Health
• 22 Oct: UNICEF and Gavi agree to cut Mosqivac malaria vaccine price by 40%. Reuters
• 23 Oct: First participant vaccinated in pivotal Phase 2/3 Bundibugyo vaccine trial in DRC. CEPI
• 23 Oct: How viruses hijack mosquito saliva to help them infect us. Gavi
• 23 Oct: Long-acting injected combo drug keeps HIV in check, real-world study finds. CIDRAP
• 23 Oct: Most Countries Give Thumps Up for UN Political Declaration on Pandemics, Give Currency to The Negotiations on the WHO Pathogen Access & Benefit Sharing Mechanism. Geneva Health Files
• 26 Oct: Global Diagnostics Coalition urges action as 47% lack access to timely diagnosis. DeviDiscourse
• 26 Oct: Strengthening Africa’s outbreak-ready evidence generation capabilities. CEPI
• 27 Oct: Devex Newswire: Big news on who's behind Anthropic's Public Benefit Fund. Devex
• 27 Oct: New EU-funded project to advance rapid diagnosis of childhood infections in Africa. Imperial
• 27 Oct: The New TB Vaccines Are Coming! How Can We Prepare for the Rollout?. Gavi
• 28 Oct: Research organization IAVI receives US funding for Ebola vaccine development. Reuters
• 28 Oct: WHO releases target regimen profiles for long-acting injectables for TB. WHO
• 28 Oct: Ebola vaccines must reach outbreak-affected communities and countries without delay. MSF
• 29 Oct: EMA and AMA’s Joint Ebola Vaccine Guidance Is a Regulatory Harmonization Blueprint Sponsors Can’t Afford to Miss. The Vanguard
• 29 Oct: Abuja Ministerial Meeting Offers Governments a Chance to Recommit to Fighting AMR. Health Policy Watch
• 29 Oct: The hard work of health sovereignty starts now. Devex
• 30 Oct: In Kilifi, Kenya, malaria is vanishing from the children’s wards. Gavi
• 30 Oct: EXCLUSIVE: Dismissing Geneva Mergers, Global Fund’s Dybul Wants to Focus on Country Capacity. Health Policy Watch
Upcoming Meetings/ Webinars
--------------------------